Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
Emmanuel Mignot, David Mayleben, Ingo Fietze, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 2, pp. 125-139
Closed Access | Times Cited: 145

Showing 26-50 of 145 citing articles:

Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Shahrokh Javaheri, Sogol Javaheri, David Gozal, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 13, pp. 1224-1240
Closed Access | Times Cited: 5
The interaction between orexin, sleep deprivation and Alzheimer’s disease: Unveiling an Emerging Connection
Masoumeh Kourosh‐Arami, Mahdi Ramezani, Alireza Komaki‬
The Journal of Physiological Sciences (2025) Vol. 75, Iss. 1, pp. 100004-100004
Open Access
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Discovery of IDOR-1117-1680, a dual orexin receptor antagonist with fast onset and short duration of action for the treatment of insomnia
Jean‐Philippe Surivet, Elise M. Jacob, Melanie Keßler, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 122, pp. 118132-118132
Closed Access
A Preliminary Report on the Effects of Daridorexant in Patients with Comorbid Insomnia and Substance Use Disorders
Marco Di Nicola, Maria Pepe, Lorenzo Bonomo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 378-378
Open Access
A randomised crossover trial of daridorexant for the treatment of chronic insomnia and nocturia
Katharina Lederer, Heike Beneš, Alan Fine, et al.
Journal of Sleep Research (2025)
Open Access
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in Adults
Andrew Briggs, François-Xavier Chalet, Jacie Cooper, et al.
PharmacoEconomics - Open (2025)
Open Access
New treatments to put insomnia to bed
Rachel Nuwer
Nature (2025)
Closed Access
Driving Performance after Bedtime Administration of Daridorexant, Assessed in a Sensitive Simulator
Clemens Muehlan, Sander Brooks, Cédric Vaillant, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 111, Iss. 6, pp. 1334-1342
Open Access | Times Cited: 20
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Objective multi-night sleep monitoring at home: variability of sleep parameters between nights and implications for the reliability of sleep assessment in clinical trials
Alexandre Chouraki, Julia Tournant, Pierrick J. Arnal, et al.
SLEEP (2022) Vol. 46, Iss. 5
Closed Access | Times Cited: 20
Daridorexant for the treatment of insomnia disorder: A systematic review and meta-analysis of randomized controlled trials
Feiyu Jiang, Hang Li, Yanting Chen, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32754-e32754
Open Access | Times Cited: 12
Long-Term Use of Insomnia Medications: An Appraisal of the Current Clinical and Scientific Evidence
Phyllis C. Zee, Suzanne M. Bertisch, Charles M. Morin, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1629-1629
Open Access | Times Cited: 12
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
Rebeka Bustamante Rocha, Fernanda Ferreira Bomtempo, Gabriela Borges Nager, et al.
Arquivos de Neuro-Psiquiatria (2023) Vol. 81, Iss. 05, pp. 475-483
Open Access | Times Cited: 11
Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: Results of a naturalistic study with 3 months follow‐up
Laura Palagini, Gaspare Alfì, Riccardo Gurrieri, et al.
Journal of Sleep Research (2024)
Closed Access | Times Cited: 4
Grundlagen und praktische Anwendung von Hypnotika
Michael Paulzen, Vanessa Münstermann
Somnologie - Schlafforschung und Schlafmedizin (2025)
Closed Access
Sleep abnormalities are associated with greater cognitive deficits and disease activity in Huntington’s disease: a 12-year polysomnographic study
Zanna Voysey, Anna Goodman, Lorraine Rogers, et al.
Brain Communications (2025) Vol. 7, Iss. 2
Open Access
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
Tobias Di Marco, Thomas E. Scammell, Michael Meinel, et al.
CNS Drugs (2023) Vol. 37, Iss. 7, pp. 639-653
Open Access | Times Cited: 10
Do Insomnia Treatments Improve Daytime Function?
Nathaniel F. Watson, Suzanne M. Bertisch, Charles M. Morin, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3089-3089
Open Access | Times Cited: 9
Daridorexant treatment for chronic insomnia: a real-world retrospective single-center study
Mariana Fernandes, Fabio Placidi, Nicola Biagio Mercuri, et al.
Neurological Sciences (2024) Vol. 45, Iss. 7, pp. 3443-3448
Open Access | Times Cited: 3
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?
Alice Caldiroli, Letizia Maria Affaticati, Enrico Capuzzi, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 3
Hyperarousal features in the sleep architecture of individuals with and without insomnia
Tobias Di Marco, Thomas E. Scammell, Kolia Sadeghi, et al.
Journal of Sleep Research (2024)
Open Access | Times Cited: 3
Daridorexant for the Treatment of Insomnia
Christopher L. Robinson, Rajesh Supra, Evan Downs, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 15

Scroll to top